Journal Article

Burden, Outcome, and Comorbidities of Extrahepatic Manifestations in Hepatitis B Virus Infections

Nugent, Kenneth, Chaisrimaneepan, Nattanicha, Songtanin, Busara, Mendóza, Roberto

2024

Overview

Hepatitis B virus (HBV) infections affect approximately 296 million people around the world, and the prevalence of any past or present HBV infection during the years 2015–2018 was as high as 4.3%. Acute HBV infection often presents with nonspecific symptoms and is usually self-limited, but 5% of patients can have persistent infections leading to chronic HBV infection and the risk of turning into chronic HBV infection is significantly higher in babies with vertical transmission (95%). Patients with chronic HBV infection are usually asymptomatic, but 15 to 40% of chronic HBV carriers develop cirrhosis and/or hepatocellular carcinoma. In addition to liver-related disorders, HBV is also associated with several extrahepatic complications, including glomerulonephritis, cryoglobulinemia, neurologic disorders, psychological manifestations, polyarthritis, and dermatologic disorders. Making the diagnosis of HBV can be challenging since patients with chronic infections can remain symptom-free for decades before developing cirrhosis or hepatocellular carcinoma, and patients with acute HBV infection may have only mild, nonspecific symptoms. Therefore, understanding how this virus causes extrahepatic complications can help clinicians consider this possibility in patients with diverse symptom presentations. The pathophysiology of these extrahepatic disorders likely involves immune-related tissue injury following immune complex formation and inflammatory cascades. In some cases, direct viral infection of extrahepatic tissue may cause a clinical syndrome. Currently, the American Association for the Study of Liver Diseases recommends treatment of chronic HBV infections with interferon therapy and/or nucleos(t)ide analogs, and this treatment has been reported to improve some extrahepatic disorders in some patients with chronic HBV infection. These extrahepatic complications have a significant role in disease outcomes and increase medical costs, morbidity, and mortality. Therefore, understanding the frequency and pathogenesis of these extrahepatic complications provides important information for both specialists and nonspecialists and may help clinicians identify patients at an earlier stage of their infection.

• Publisher: MDPI AG,MDPI
• Subject: Analysis / antigen-antibody complex / Antiviral Agents - therapeutic use / Apheresis / arthritis / B cells / Biological response modifiers / burden / Carcinoma, Hepatocellular - epidemiology / Carcinoma, Hepatocellular - virology / Chronic infection / Cirrhosis / Comorbidity / Complications and side effects / Cost of Illness / Cryoglobulinemia / Development and progression / Diseases / Drug resistance / Evolution & development / extrahepatic manifestation / Glomerulonephritis / Hepatitis B / Hepatitis B - complications / Hepatitis B - epidemiology / hepatitis B infection / Hepatitis B virus / Hepatitis B virus - physiology / Hepatitis B, Chronic - complications / Hepatitis B, Chronic - epidemiology / Hepatitis C / Hepatocellular carcinoma / hepatoma / Humans / Infections / Inflammation / interferons / Liver / Liver cancer / Liver cirrhosis / Liver Cirrhosis - epidemiology / Liver Cirrhosis - virology / Liver diseases / Liver Neoplasms - epidemiology / Liver Neoplasms - virology / Medical research / Medicine, Experimental / Morbidity / mortality / Neurological complications / Pathogenesis / pathophysiology / Patient outcomes / Patients / Peripheral neuropathy / Plasma / Polyarthritis / Prevalence / Proteins / Purpura / Review / risk / therapeutics / Viral infections / Viruses